hyaluronidase (bovine) (Wydase) Report issue

Animal product Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid. Karl Meyer classified these enzymes in 1971, into three distinct groups, a scheme based on the enzyme reaction products. The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

amphadase | diffusin | enzodase | hyal-1 | hyalase | hyaluronidase | hyaluronidase bovine | hyaluronidase (glycoprotein, sheep testis isoenzyme) | hyaluronidase ovine | hyaluronidase (ovine) | hyaluronidase, ovine | hyaluronidase ph-20 | hyaluronidase (sheep testis isoenzyme) | hyazyme | hydase | hyo6a | jalovis

Organizations (21)

Research & Development (15)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (7)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (14)

Approved Indications (1)


 

Urography (approved 1950)

Experimental Indications - Clinical Trial Phases 1-4 (13)


 

Arrhythmias, Cardiac (Phase 4)

Cardiovascular Diseases (Phase 3)

Chronic Pain (Early Phase 1)

Coronary Disease (Phase 3)

Dermatology (Phase 2)

Diabetes Mellitus, Type 1 (Early Phase 1)

Heart Diseases (Phase 3)

Multiple Myeloma (Early Phase 1)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Neuralgia (Early Phase 1)

Pharmacological and Toxicological Phenomena (Early Phase 1)

Renal Insufficiency (Early Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial Organizations: 15

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue